User Fees Could Be Tough Sell On Capitol Hill
Executive Summary
The fate in the Senate of fees on industry to pay for new FDA food safety responsibilities underscores the tough climate on Capitol Hill for new industry assessments to improve FDA oversight of drugs.
You may also be interested in...
FDA Budget Spared Deepest Cuts As House Republicans Seek To Slash Spending In FY'11
Initial round of funding cuts from the House Appropriations Committee would eliminate $220 million from President Obama's spending plan for the agency.
Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal
Mylan President Heather Bresch is drawing attention to the economic implications of not inspecting overseas drug manufacturing facilities as she seeks congressional support for generic user fees to finance such activities.
Establishment Fees Protect American Manufacturing, Mylan Argues In User Fee Proposal
Mylan President Heather Bresch is drawing attention to the economic implications of not inspecting overseas drug manufacturing facilities as she seeks congressional support for generic user fees to finance such activities.